{"title":"ICB Special Feature: Highlights of 2023","authors":"Joanne H Reed","doi":"10.1111/imcb.12792","DOIUrl":null,"url":null,"abstract":"<p>In this Special Feature, we bring you the “Highlights of 2023”, a collection of short articles that discuss key research findings published in 2023 that advanced a specific research area of immunology. Booty<span><sup>1</sup></span> discusses recent mechanistic insights in T-cell immunometabolism, highlighting pathways and metabolites that modulate T effector and T regulatory (Treg) cell function in cancer and autoimmunity. Zhang and Chong<span><sup>2</sup></span> review key findings demonstrating the roles of microRNA in T-cell apoptosis and differentiation and Treg proliferation in experimental autoimmune encephalomyelitis and myeloma. Makuyana and Liston<span><sup>3</sup></span> focus on publications revealing new functions for Treg cells in the lung, including in alveolar regeneration. Guo <i>et al</i>.<span><sup>4</sup></span> highlight work that has advanced our understanding of age-related effects on T cells with large-scale analyses showing genetic, transcriptomic and T-cell receptor repertoire changes with age. Pasquin<span><sup>5</sup></span> discusses key findings in the functional characterization and diversity of γδ T cells and mucosal-associated invariant T (MAIT) cells. Cellular therapy was a pivotal theme in 2023. Chinni <i>et al</i>.<span><sup>6</sup></span> highlight findings demonstrating how CD4<sup>+</sup> T cells impact the manufacturing and quality of chimeric antigen receptor (CAR) T-cell products and contribute to long-term tumor control and adverse events such as cytokine release syndrome. Lee and Reed<span><sup>7</sup></span> discuss current clinical trials and basic research studies that are improving the specificity, safety and accessibility of CAR T-cell therapy for autoimmune disease. Bourel and Lesage<span><sup>8</sup></span> focus on publications defining the phenotypic, genetic and functional attributes that influence natural killer (NK) cell–mediated killing of tumor cells for the development of NK cellular therapies. Lam and Souza-Fonseca-Guimaraes<span><sup>9</sup></span> continue the NK cell theme, highlighting technological advances in genomics and proteomics that elucidate key functions of NK cells in cancer and infection. Lombard-Vadnais and Lesage<span><sup>10</sup></span> uncover the role of class switching in thymic B cells for negative selection of CD4<sup>+</sup> thymocytes and Treg generation. Barra and Marshall<span><sup>11</sup></span> highlight key findings on the diversity and function of mast cells and how they integrate with host defense to prevent immune-mediated damage in barrier tissues and the central nervous system. Dashwood and Liston<span><sup>12</sup></span> bring us up to date on microglia biology, with mechanistic insights into cognitive development, synaptic pruning and new approaches to evaluate microglia function. Van Nieuwenhove<span><sup>13</sup></span> highlights major translational advances in the detection and treatment of monogenic and polygenic pediatric immune deficiencies, autoimmunity and autoinflammation. Pankhurst and Linterman<span><sup>14</sup></span> summarize many key discoveries in the germinal center field and the implications for long-lived humoral immunity. Together, this collection of Research Highlights is designed to update and celebrate key discoveries in immunology in 2023.</p><p>The author declares no conflicts of interest.</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":"102 6","pages":"412-413"},"PeriodicalIF":3.2000,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imcb.12792","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology & Cell Biology","FirstCategoryId":"2","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/imcb.12792","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
In this Special Feature, we bring you the “Highlights of 2023”, a collection of short articles that discuss key research findings published in 2023 that advanced a specific research area of immunology. Booty1 discusses recent mechanistic insights in T-cell immunometabolism, highlighting pathways and metabolites that modulate T effector and T regulatory (Treg) cell function in cancer and autoimmunity. Zhang and Chong2 review key findings demonstrating the roles of microRNA in T-cell apoptosis and differentiation and Treg proliferation in experimental autoimmune encephalomyelitis and myeloma. Makuyana and Liston3 focus on publications revealing new functions for Treg cells in the lung, including in alveolar regeneration. Guo et al.4 highlight work that has advanced our understanding of age-related effects on T cells with large-scale analyses showing genetic, transcriptomic and T-cell receptor repertoire changes with age. Pasquin5 discusses key findings in the functional characterization and diversity of γδ T cells and mucosal-associated invariant T (MAIT) cells. Cellular therapy was a pivotal theme in 2023. Chinni et al.6 highlight findings demonstrating how CD4+ T cells impact the manufacturing and quality of chimeric antigen receptor (CAR) T-cell products and contribute to long-term tumor control and adverse events such as cytokine release syndrome. Lee and Reed7 discuss current clinical trials and basic research studies that are improving the specificity, safety and accessibility of CAR T-cell therapy for autoimmune disease. Bourel and Lesage8 focus on publications defining the phenotypic, genetic and functional attributes that influence natural killer (NK) cell–mediated killing of tumor cells for the development of NK cellular therapies. Lam and Souza-Fonseca-Guimaraes9 continue the NK cell theme, highlighting technological advances in genomics and proteomics that elucidate key functions of NK cells in cancer and infection. Lombard-Vadnais and Lesage10 uncover the role of class switching in thymic B cells for negative selection of CD4+ thymocytes and Treg generation. Barra and Marshall11 highlight key findings on the diversity and function of mast cells and how they integrate with host defense to prevent immune-mediated damage in barrier tissues and the central nervous system. Dashwood and Liston12 bring us up to date on microglia biology, with mechanistic insights into cognitive development, synaptic pruning and new approaches to evaluate microglia function. Van Nieuwenhove13 highlights major translational advances in the detection and treatment of monogenic and polygenic pediatric immune deficiencies, autoimmunity and autoinflammation. Pankhurst and Linterman14 summarize many key discoveries in the germinal center field and the implications for long-lived humoral immunity. Together, this collection of Research Highlights is designed to update and celebrate key discoveries in immunology in 2023.
期刊介绍:
The Australasian Society for Immunology Incorporated (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.